![Mark Vaeck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Vaeck
Gründer bei
Complix NV
Profil
Mark Vaeck is the founder of three companies.
He founded Ablynx NV in 2001, Intrexon ActoBiotics NV in 2006, and Complix NV in 2008.
At Ablynx NV, he was an Advisor from 2001 to 2009.
At Intrexon ActoBiotics NV, he was the Chief Executive Officer in 2010.
At Complix NV, he is currently the Chief Executive Officer & Director.
Dr. Vaeck's former jobs include being the Chief Executive Officer of KeyGene NV from 1993 to 1998, Director-Business Development at Chiron Corp.
from 1983 to 1993, Chief Operating Officer of Ceres, Inc. (California) in 2001, Member-Supervisory Board at InteRNA Technologies BV from 2013 to 2021, Licensing Manager at UCB Pharma SA (Belgium) in 1993, and Manager-Business Development at Bayer Bioscience NV.
Dr. Vaeck received a doctorate degree from Université Libre de Bruxelles in 1982.
Aktive Positionen von Mark Vaeck
| Unternehmen | Position | Beginn |
|---|---|---|
Complix NV
 Complix NV Pharmaceuticals: MajorHealth Technology Engages in the development of biopharmaceutical | Gründer | 01.01.2011 |
Ehemalige bekannte Positionen von Mark Vaeck
| Unternehmen | Position | Ende |
|---|---|---|
InteRNA Technologies BV
 InteRNA Technologies BV BiotechnologyHealth Technology Engages in the development of novel breakthrough therapies in chronic disorders | Direktor/Vorstandsmitglied | 12.10.2021 |
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Manufactures biopharmaceutical products | Gründer | 01.01.2010 |
| CERES INC | Geschäftsführer | 01.01.2001 |
KeyGene NV
 KeyGene NV Miscellaneous Commercial ServicesCommercial Services Provides genetic and genomic research services | Präsident | - |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Corporate Officer/Principal | 01.01.1993 |
Ausbildung von Mark Vaeck
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
79
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
KeyGene NV
KeyGene NV Miscellaneous Commercial ServicesCommercial Services Provides genetic and genomic research services | Commercial Services |
Ceres, Inc. (California)
 Ceres, Inc. (California) Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit driving sustainability via investor and corporate networks for climate action, water stewardship and nature restoration | Commercial Services |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
Université Libre de Bruxelles
 Université Libre de Bruxelles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intrexon ActoBiotics NV
Intrexon ActoBiotics NV BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
Complix NV
Complix NV Pharmaceuticals: MajorHealth Technology Engages in the development of biopharmaceutical | Health Technology |
InteRNA Technologies BV
InteRNA Technologies BV BiotechnologyHealth Technology Engages in the development of novel breakthrough therapies in chronic disorders | Health Technology |
UCB Pharma SA (Belgium)
 UCB Pharma SA (Belgium) Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Bayer Bioscience NV
 Bayer Bioscience NV Chemicals: AgriculturalProcess Industries Manufactures and markets herbicides & agricultural chemical products | Process Industries |
Wählen Sie MarketScreener 
